484 related articles for article (PubMed ID: 26374449)
1. New insights on the role of the endocannabinoid system in the regulation of energy balance.
Gatta-Cherifi B; Cota D
Int J Obes (Lond); 2016 Feb; 40(2):210-9. PubMed ID: 26374449
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids and Metabolic Disorders.
Gatta-Cherifi B; Cota D
Handb Exp Pharmacol; 2015; 231():367-91. PubMed ID: 26408168
[TBL] [Abstract][Full Text] [Related]
3. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
Simon V; Cota D
Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
[TBL] [Abstract][Full Text] [Related]
4. The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.
Bermudez-Silva FJ; Cardinal P; Cota D
J Psychopharmacol; 2012 Jan; 26(1):114-24. PubMed ID: 21824982
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoid control of food intake and energy balance.
Di Marzo V; Matias I
Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
[TBL] [Abstract][Full Text] [Related]
7. Energy balance regulation by endocannabinoids at central and peripheral levels.
Quarta C; Mazza R; Obici S; Pasquali R; Pagotto U
Trends Mol Med; 2011 Sep; 17(9):518-26. PubMed ID: 21816675
[TBL] [Abstract][Full Text] [Related]
8. Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.
Silvestri C; Di Marzo V
Expert Opin Investig Drugs; 2012 Sep; 21(9):1309-22. PubMed ID: 22780328
[TBL] [Abstract][Full Text] [Related]
9. [A role for the endocannabinoid system in obesity].
Valenzuela C; Aguirre C; Castillo V; Ronco AM; Llanos M
Rev Med Chil; 2010 May; 138(5):621-9. PubMed ID: 20668819
[TBL] [Abstract][Full Text] [Related]
10. Role of the endocannabinoid system in energy balance regulation and obesity.
Cota D
Front Horm Res; 2008; 36():135-145. PubMed ID: 18230900
[TBL] [Abstract][Full Text] [Related]
11. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
Pagotto U; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
[TBL] [Abstract][Full Text] [Related]
12. The brain endocannabinoid system in the regulation of energy balance.
Richard D; Guesdon B; Timofeeva E
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):17-32. PubMed ID: 19285258
[TBL] [Abstract][Full Text] [Related]
13. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
[TBL] [Abstract][Full Text] [Related]
14. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.
Bowles NP; Karatsoreos IN; Li X; Vemuri VK; Wood JA; Li Z; Tamashiro KL; Schwartz GJ; Makriyannis AM; Kunos G; Hillard CJ; McEwen BS; Hill MN
Proc Natl Acad Sci U S A; 2015 Jan; 112(1):285-90. PubMed ID: 25535367
[TBL] [Abstract][Full Text] [Related]
15. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
de Kloet AD; Woods SC
Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.
Silvestri C; Di Marzo V
Cell Metab; 2013 Apr; 17(4):475-90. PubMed ID: 23562074
[TBL] [Abstract][Full Text] [Related]
17. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.
Heyman E; Gamelin FX; Aucouturier J; Di Marzo V
Obes Rev; 2012 Dec; 13(12):1110-24. PubMed ID: 22943701
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid receptor 1 and its role in influencing peripheral metabolism.
O'Keefe L; Simcocks AC; Hryciw DH; Mathai ML; McAinch AJ
Diabetes Obes Metab; 2014 Apr; 16(4):294-304. PubMed ID: 23782485
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
[TBL] [Abstract][Full Text] [Related]
20. Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockade.
Engeli S
Obes Facts; 2008; 1(1):8-15. PubMed ID: 20054157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
